Astera Labs (NASDAQ:ALAB) Stock Price Target Raised at Morgan Stanley

Posted by Francis Steltz on Nov 5th, 2026

Astera Labs (NASDAQ:ALAB – Free Report) had its price target hoisted by Morgan Stanley from $382.00 to $389.00 in a research report released on Wednesday,Benzinga reports. Morgan Stanley currently has an overweight rating on the stock.

Several other equities research analysts also recently issued reports on ALAB. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Susquehanna cut their price target on Astera Labs from $310.00 to $258.00 and set a “neutral” rating on the stock in a report on Wednesday. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 target price for the company in a research report on Wednesday. Citigroup cut Astera Labs from a “buy” rating to a “hold” rating in a research report on Friday, October 9th. Finally, UBS Group cut their target price on shares of Astera Labs from $300.00 to $290.00 and set a “neutral” rating for the company in a research note on Wednesday. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $318.00.

Get Our Latest Analysis on Astera Labs

Astera Labs Trading Down 4.4%

Shares of ALAB opened at $223.27 on Wednesday. The firm has a market cap of $38.73 billion, a PE ratio of 88.95 and a beta of 3.85. Astera Labs has a 12-month low of $97.89 and a 12-month high of $499.48. The company’s 50 day simple moving average is $304.94 and its 200-day simple moving average is $255.78.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. The company had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 27.30%. Astera Labs’s quarterly revenue was up 153.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.49 EPS. As a group, equities research analysts forecast that Astera Labs will post 2.71 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 396,059 shares of company stock valued at $123,408,470 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

A number of institutional investors and hedge funds have recently modified their holdings of the company. Lido Advisors LLC lifted its position in Astera Labs by 114.8% during the 3rd quarter. Lido Advisors LLC now owns 27,630 shares of the company’s stock worth $9,836,000 after acquiring an additional 14,768 shares during the last quarter. Keybank National Association OH lifted its holdings in shares of Astera Labs by 139.8% during the 3rd quarter. Keybank National Association OH now owns 2,103 shares of the company’s stock worth $749,000 after acquiring an additional 1,226 shares during the period. Csenge Advisory Group acquired a new stake in Astera Labs during the third quarter valued at approximately $534,000. 71 West Capital Partners bought a new position in shares of Astera Labs during the third quarter valued at $208,000. Finally, AlphaCore Capital LLC acquired a new stake in shares of Astera Labs during the third quarter worth approximately $752,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Q3 earnings of $1.32 per share beat the $1.19 consensus, while revenue of $584.9 million exceeded estimates and rose 153.6% year over year. Scorpio switches, including the X-Series, were a key growth driver. Article: Astera Labs Q3 Earnings and Revenues Beat Estimates
Positive Sentiment: Management forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Expansion into optical connectivity, memory and rack-scale AI systems may provide additional growth opportunities. Article: ALAB Q3 Earnings Call Highlights Scorpio Ramp and New Growth Engines
Neutral Sentiment: Analyst opinions were mixed: Northland upgraded ALAB to Outperform and Morgan Stanley raised its price target, while several firms lowered targets; RBC maintained an Outperform rating. Article: Northland Securities stock recommendations
Negative Sentiment: Shares fell despite the earnings beat, suggesting results and guidance may not have been enough to satisfy expectations. Analysts flagged a premium valuation, rising costs, reliance on a limited number of customers and competition—particularly Marvell’s optical push—as risks to future growth. Article: Astera Labs Stock Falls Despite Strong Earnings. Its Growth Story Is Intact.

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.